CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Revenue:
Patient revenue	$ 617,000	$ 503,000	$ 1,681,000	$ 1,547,000
Expenses:
Patient expenses	187,000	277,000	613,000	604,000
Selling, general and administrative	279,000	255,000	767,000	743,000
Total	466,000	532,000	1,380,000	1,347,000
Operating income	151,000	(29,000)	301,000	200,000
Gain (loss) from investment in unconsolidated entities, net	23,000	(32,000)
Interest expense	(53,000)	(70,000)	(169,000)	(206,000)
Gain from sales of investments in unconsolidated entities			24,000	0
Gain (loss) from invesment in unconsolidated entities			8,000	(32,000)
Interest income	4,000	0	12,000	0
Income from continuing operations			176,000	(38,000)
Discontinued operations
Impairment loss			0	(89,000)
Gain from operations			0	28,000
Gain (loss) from discontinued operations			0	(61,000)
Net income (loss)	$ 125,000	$ (131,000)	$ 176,000	$ (99,000)
Basic and diluted income (loss) per share (in dollars per share)	$ 0.02	$ (0.02)	$ 0.02	$ (0.01)
Net income per common share from continuing operations - basic and diluted (in dollars per share)			$ 0.02	$ 0
Net income (loss) per common share from discontinued operations - basic and diluted (in dollars per share)			$ 0	$ (0.01)
Weighted average shares outstanding (in shares)	7,797,185	7,747,185	7,797,185	7,747,185